Literature DB >> 28740656

Biomarkers in the era of individualized medicine.

Chang Hyun Kang1.   

Abstract

Year:  2017        PMID： 28740656      PMCID： PMC5506155          DOI： 10.21037/jtd.2017.05.55

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  7 in total

1.  Prognostic and predictive role of epidermal growth factor receptor mutation in recurrent pulmonary adenocarcinoma after curative resection.

Authors:  Jae Hyun Jeon; Chang Hyun Kang; Hye-seon Kim; Yong Won Seong; In Kyu Park; Young Tae Kim
Journal:  Eur J Cardiothorac Surg       Date:  2014-04-22       Impact factor: 4.191

2.  Epidermal Growth Factor Receptor Mutations and Prognosis in Pathologic N1-N2 Pulmonary Adenocarcinoma.

Authors:  Tetsuya Isaka; Haruhiko Nakayama; Tomoyuki Yokose; Hiroyuki Ito; Yohei Miyagi; Tomohiko Matsuzaki; Masashi Nagata; Hideyuki Furumoto; Teppei Nishii; Kayoko Katayama; Kouzo Yamada; Munetaka Masuda
Journal:  Ann Thorac Surg       Date:  2016-08-20       Impact factor: 4.330

3.  The presence of mutations in epidermal growth factor receptor gene is not a prognostic factor for long-term outcome after surgical resection of non-small-cell lung cancer.

Authors:  Young Tae Kim; Yong Won Seong; Yoo Jin Jung; Yoon Kyung Jeon; In Kyu Park; Chang Hyun Kang; Joo Hyun Kim
Journal:  J Thorac Oncol       Date:  2013-02       Impact factor: 15.609

4.  Impact of the epidermal growth factor receptor mutation status on the post-recurrence survival of patients with surgically resected non-small-cell lung cancer.

Authors:  Tomoyoshi Takenaka; Mitsuhiro Takenoyama; Masafumi Yamaguchi; Ryo Toyozawa; Eiko Inamasu; Miyako Kojo; Gouji Toyokawa; Tsukihisa Yoshida; Yoshimasa Shiraishi; Yosuke Morodomi; Fumihiko Hirai; Kenichi Taguchi; Mototsugu Shimokawa; Takashi Seto; Yukito Ichinose
Journal:  Eur J Cardiothorac Surg       Date:  2014-06-03       Impact factor: 4.191

5.  The impact of EGFR mutation status on outcomes in patients with resected stage I non-small cell lung cancers.

Authors:  Benjamin Izar; Lecia Sequist; Mihan Lee; Alona Muzikansky; Rebecca Heist; John Iafrate; Dora Dias-Santagata; Douglas Mathisen; Michael Lanuti
Journal:  Ann Thorac Surg       Date:  2013-08-08       Impact factor: 4.330

6.  Epidermal growth factor receptor mutation and treatment outcome of mediastinoscopic N2 positive non-small cell lung cancer patients treated with neoadjuvant chemoradiotherapy followed by surgery.

Authors:  Hee Kyung Ahn; Yoon-La Choi; Joung Ho Han; Yong Chan Ahn; Kwhanmien Kim; Jhingook Kim; Young Mog Shim; Sang-Won Um; Hojoong Kim; O Jung Kwon; Jong-Mu Sun; Jin Seok Ahn; Keunchil Park; Myung-Ju Ahn
Journal:  Lung Cancer       Date:  2012-12-21       Impact factor: 5.705

7.  The Association of EGFR Mutations with Stage at Diagnosis in Lung Adenocarcinomas.

Authors:  Jaeyoung Cho; Sun Mi Choi; Jinwoo Lee; Chang-Hoon Lee; Sang-Min Lee; Jae-Joon Yim; Doo Hyun Chung; Chul-Gyu Yoo; Young Whan Kim; Sung Koo Han; Young Sik Park
Journal:  PLoS One       Date:  2016-11-18       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.